Orchestra BioMed Holdings, Inc. (OBIO) compared with its closest peers (TLSI, RCEL, EMBC, TMCI, ANIK). Peer set by Business model: Medical Devices / Life Science Tools; 10 closest by market cap; US-domiciled. First-party data.
| Company | Market Cap | P/E |
|---|---|---|
| TriSalus Life Sciences, Inc. (TLSI) | $322.44M | -3.8 |
| AVITA Medical, Inc. (RCEL) | $311.43M | -2.0 |
| Embecta Corp. (EMBC) | $309.93M | 3.5 |
| Treace Medical Concepts, Inc. (TMCI) | $288.36M | -2.6 |
| Anika Therapeutics, Inc. (ANIK) | $286.26M | -12.7 |
| OraSure Technologies, Inc. (OSUR) | $258.63M | -2.6 |
| InfuSystem Holdings, Inc. (INFU) | $242.59M | 28.4 |
| Utah Medical Products, Inc. (UTMD) | $227.34M | 21.6 |
| Neuronetics, Inc. (STIM) | $215.03M | -2.3 |
| IceCure Medical Ltd (ICCM) | $179.15M | — |
| Sector P/E (Healthcare) | 21.6 |
| Industry P/E (Medical Equipment) | 32.9 |
OBIO overview · OBIO earnings · OBIO financials · OBIO KPIs · OBIO investor relations · OBIO ownership · OBIO filings
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.